A randomized, open-label study of MabThera retreatment on treatment response in patients with active rheumatoid arthritis and inadequate response to anti-TNF therapy.

Trial Profile

A randomized, open-label study of MabThera retreatment on treatment response in patients with active rheumatoid arthritis and inadequate response to anti-TNF therapy.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 05 Aug 2010

At a glance

  • Drugs Rituximab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 16 Apr 2010 Planned initiation date (Jan 2000) added as reported by Roche record.
    • 25 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by Roche record.
    • 23 Feb 2010 Status changed from active, no longer recruiting to recruiting as reported by Roche record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top